Chemotherapy Protocols
Although these pages are public, the chemotherapy information within them is for Cancer Alliance staff and therefore the language may appear confusing to those who do not work in this area.
Disclaimer:
The chemotherapy protocols available on this website are maintained by the Lancashire and South Cumbria Network Pharmacist David Barber. The Cancer Alliance is not responsible for the content or upkeep of the protocols. If you have any queries about the protocols please contact David Barber: Tel 01772 522339 or david.barber@lthtr.nhs.uk
Cancer Alliance Clinical Trials- (Summaries for out of hours)
Amplitude - Clinical trials summary for out of hours
Astefania - Clinical trials summary for out of hours
Checkmate 848 Solid Tumour Trial CA209848 - Clinical trials summary for out of hours
Couplet - Clinical trials summary for out of hours- Phase 1b V 1 10-10-18 (October 2018)
CYPIDES - Clinical Study Protocol (Version 12)
Imvigor011 - Clinical trials summary for out of hours
POD1UM303 - Clinical trials summary for out of hours
Seattle GENETICS EV302 - Clinical trials summary for out of hours
TROPiCS-04 - Clinical trials summary for out of hours
lidERA (GO42784) - Clinical trials summary for out of hours
TALAPRO - Clinical trials out of hours summary.pdf
MK3475-U03 - Clinical trials summary for out of hours
COLUMBUS AD - EORTC - Clinical trials summary for out of hours
STELLAR Study XL092-001- Clinical trials summary for out of hours
MODIFY MODI1 - Clinical trials summary for out of hours
SUNRISE4 - Clinical trials summary for out of hours
HeredERA - Clinical trials summary for out of hours
SCOPE Study- Clinical trials summary for out of hours
BL13 - Clinical trials summary for out of hours (A RANDOMIZED PHASE II TRIAL ASSESSINGTRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB (MEDI4736) TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER)
TRIDENT Commercial Study - Clinical trials summary for out of hours
CYPIDES - Clinical trials summary for out of hours
AURORA Study - Clinical trials summary for out of hours
JAVELIN - Clinical trials summary for out of hours
Shattuck Labs SL03-OHD-105 - Mirvetuximab Soravtansine - CHEMOTHERAPY INSTRUCTIONS
Shattuck Labs SL03-OHD-105 - Clinical trials summary for out of hours
MK3475-992_IRAS 1003217_Clinical Trials Summary for out of hours.docx
WO43919 - INAVO121 IRAS 1007071_Clinical Trials Summary for out of hours.docx
BNT122-01 Clinical Trials Summary for out of hours.pdf
MORAb - 202-G000-20 - Clinical trials summary for out of hours